Free Trial

Upstream Bio (UPB) Earnings Date, Estimates & Call Transcripts

Upstream Bio logo
$3.38 -0.20 (-5.59%)
Closing price 04:00 PM Eastern
Extended Trading
$3.36 -0.01 (-0.44%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Upstream Bio Earnings Summary

Upstream Bio announced Q3 2026 earnings on November 10, 2026, reporting an EPS of -$0.75, which missed analysts' consensus estimates of -$0.73 by $0.02. Quarterly revenue was reported to be $395 thousand, below analysts' expectations of $522 thousand. With a trailing EPS of -$2.90, Upstream Bio's earnings are expected to grow next year, from ($2.84) to ($2.77) per share.

Latest Q3
Earnings Date
Nov. 10Estimated
Consensus EPS
(Nov. 10)
-$0.73
Actual EPS
(Nov. 10)
-$0.75 Missed By -$0.02
Actual Revenue
(Nov. 10)
$0.40M

Q3 2026 Earnings Resources

Get Upstream Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Upstream Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

UPB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UPB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Upstream Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.78-$0.78-$0.78
Q2 20263-$0.78-$0.68-$0.74
Q3 20263-$0.79-$0.63-$0.73
Q4 20263-$0.82-$0.58-$0.68
FY 202610-$3.17-$2.67-$2.93

Upstream Bio Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/10/2026Q3 2026-$0.7317-$0.7520 -$0.0203-$0.75$0.52M$0.40M
8/11/2026Q2 2026-$0.7444-$0.73+$0.0144-$0.73$0.56M$0.77M
5/13/2026Q1 2026-$0.73-$0.7470 -$0.0170-$0.75$1.03M$1.03M
3/26/2026Q4 2025-$0.73-$0.7860 -$0.0560-$0.78$0.52M$0.67M
11/5/2025Q3 2025-$0.78-$0.63+$0.15-$0.63$0.65M$0.68M
8/6/2025Q2 2025-$0.61-$0.74 -$0.13-$0.74$0.32M$0.94M
5/6/2025Q1 2025-$0.49-$0.51 -$0.02-$0.51$0.71M$0.57M

Upstream Bio Earnings - Frequently Asked Questions

Upstream Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 10th, 2026 based off last year's report dates. Learn more on UPB's earnings history.

In the previous quarter, Upstream Bio (NASDAQ:UPB) missed the analysts' consensus estimate of ($0.73) by $0.02 with a reported earnings per share (EPS) of ($0.75). Learn more on analysts' earnings estimate vs. UPB's actual earnings.

Upstream Bio's earnings report can be found in their filing with the SEC.
View SEC filing

Upstream Bio (NASDAQ:UPB) has a recorded annual revenue of $2.85 million.

Upstream Bio (NASDAQ:UPB) has a recorded net income of -$143.44 million. UPB has generated -$2.90 earnings per share over the last four quarters.

Upstream Bio's earnings are expected to grow from ($2.84) per share to ($2.77) per share in the next year.


Earnings data for NASDAQ:UPB is sourced from Fiscal.ai, with the most recent quarter reported on 11/10/2026. New results are added as companies report their earnings.
From Our Partners